Skip to content

Clinical trials

Phase 3 Latent Tuberculosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Latent Tuberculosis Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20113
20122
20141
20151
20171
20191
20211
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Unknown status2
Recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital3
McGill University2
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1
Centers for Disease Control and Prevention1
Centre Hospitalier Universitaire, Amiens1
Freundeskreis Für Internationale Tuberkulosehilfe e.V1
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla1
Harvard School of Public Health (HSPH)1
Henry M. Jackson Foundation for the Advancement of Military Medicine1
Huashan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Latent Tuberculosis15
Tuberculosis7
Mycobacterium Infections1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.